ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 1 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $279 | -87.7% | 51,200 | -84.9% | 0.00% | -100.0% |
Q2 2023 | $2,271 | -34.7% | 338,500 | -14.1% | 0.00% | -40.0% |
Q1 2023 | $3,479 | +9.5% | 394,000 | -5.2% | 0.01% | +25.0% |
Q4 2022 | $3,177 | -99.9% | 415,800 | -9.2% | 0.00% | -20.0% |
Q3 2022 | $3,260,000 | -17.2% | 457,800 | -5.9% | 0.01% | 0.0% |
Q2 2022 | $3,936,000 | -37.8% | 486,500 | +6.8% | 0.01% | -28.6% |
Q1 2022 | $6,324,000 | -2.0% | 455,600 | +184.4% | 0.01% | -12.5% |
Q1 2021 | $6,450,000 | – | 160,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |